Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1955061rdf:typepubmed:Citationlld:pubmed
pubmed-article:1955061lifeskim:mentionsumls-concept:C0013867lld:lifeskim
pubmed-article:1955061lifeskim:mentionsumls-concept:C0027686lld:lifeskim
pubmed-article:1955061lifeskim:mentionsumls-concept:C1522602lld:lifeskim
pubmed-article:1955061lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:1955061pubmed:dateCreated1992-1-2lld:pubmed
pubmed-article:1955061pubmed:abstractTextA prospective study was carried out to compare the efficacy of electroretinography, fundus fluorescein angiography and clinical examination in identifying those at risk of rubeotic glaucoma following central retinal vein occlusion (CRVO). Our preliminary observations are described. The findings suggest a complementary role for electroretinography in the management of CRVO. Particularly significant were interocular differences in 30 Hz flicker latency, the ability to elicit pattern ERGs and the ratio of scotopic and photopic a:b wave amplitudes. Of the clinical measures the depth of the relative afferent pupil defect was a sensitive indicator of rubeosis. Factors of lesser statistical prognostic value included poor visual acuity and the extent of deep retinal haemorrhages. Fundus fluorescein angiography in this study had limited value in predicting those patients at risk of rubeosis.lld:pubmed
pubmed-article:1955061pubmed:languageenglld:pubmed
pubmed-article:1955061pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955061pubmed:citationSubsetIMlld:pubmed
pubmed-article:1955061pubmed:statusMEDLINElld:pubmed
pubmed-article:1955061pubmed:issn0950-222Xlld:pubmed
pubmed-article:1955061pubmed:authorpubmed-author:ThompsonD ADAlld:pubmed
pubmed-article:1955061pubmed:authorpubmed-author:GibsonJ MJMlld:pubmed
pubmed-article:1955061pubmed:authorpubmed-author:DrasdoNNlld:pubmed
pubmed-article:1955061pubmed:authorpubmed-author:KritzingerE...lld:pubmed
pubmed-article:1955061pubmed:authorpubmed-author:MorrellA JAJlld:pubmed
pubmed-article:1955061pubmed:issnTypePrintlld:pubmed
pubmed-article:1955061pubmed:volume5 ( Pt 3)lld:pubmed
pubmed-article:1955061pubmed:ownerNLMlld:pubmed
pubmed-article:1955061pubmed:authorsCompleteYlld:pubmed
pubmed-article:1955061pubmed:pagination362-8lld:pubmed
pubmed-article:1955061pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:meshHeadingpubmed-meshheading:1955061-...lld:pubmed
pubmed-article:1955061pubmed:year1991lld:pubmed
pubmed-article:1955061pubmed:articleTitleElectroretinography as a prognostic indicator or neovascularisation in CRVO.lld:pubmed
pubmed-article:1955061pubmed:affiliationBirmingham and Midland Eye Hospital, UK.lld:pubmed
pubmed-article:1955061pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1955061pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1955061lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1955061lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1955061lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1955061lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1955061lld:pubmed